Concord Healthcare Group Co., Ltd., a joint stock company incorporated in the People's Republic of China, has announced the placement of new shares under a general mandate. The company's H shares are listed on the Main Board of the Stock Exchange with the stock code 2453. The placement will be completed in accordance with the terms and conditions set out in the Placing Agreement. The process is coordinated by a sole overall coordinator, placing agent, and capital market intermediary. The completion date for the placement is expected to be the second business day after the granting of the Listing Approval, with a final deadline by 5 June 2025.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。